ArticleJournal of gastrointestinal cancer2026
Machine Learning Prediction of Local Failure in GI Brain Metastases on the Day of Gamma Knife Radiosurgery.
Article in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTime to local failure after stereotactic radiosurgery (SRS), including Gamma Knife radiosurgery (GKRS), for gastrointestinal (GI) brain metastases is difficult to predict and may vary substantially across tumors and patients. We developed and internally evaluated a survival machine learning framework to estimate tumor-specific time to local failure using pre-SRS features.
methodsWe performed a retrospective study of GI brain metastases treated with GKRS. Local failure was modeled as a time-to-event outcome under right censoring. A Random Survival Forest survival model was trained using treatment-time demographic, clinical, tumor, histologic, and radiosurgical variables restricted to information available before or at GKRS. To avoid within-patient leakage, validation was performed using patient-grouped cross-validation. Model performance was assessed using the concordance index (C-index) and IBS. Among tumors with observed local failure, temporal prediction accuracy was additionally evaluated using mean absolute error (MAE) and coefficient of determination (R²).
resultsThe cohort included 90 patients and 218 treated tumors from 2014 to 2024. Median age at treatment was 68.0 years, median pre-treatment Karnofsky Performance Status was 60, and 91.3% of tumors occurred in patients with multiple metastases. Fifty-seven tumors experienced local failure. The model achieved a mean grouped cross-validated C-index of 0.79 and a mean IBS of 0.0031 (95% CI, 0.0014-0.0042). Among tumors with local failure, conditional MAE was 1.11 months and R² was 0.26.
conclusionsPre-SRS survival machine learning is feasible for predicting time to local failure in GI brain metastases treated with GKRS and supports further validation in larger multicenter cohorts.
Indexed as
Identifiers
42658361What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.